Track the Beta Drugs Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Beta Drugs Limited has recorded 9 public disclosures. Market capitalisation: €14.3bn. The latest transaction was reported on 13 November 2025 (Sale). Among the most active insiders: Rahul Batra. Every trade is free.
9
Insider Decl.
0
Thresholds
€56,689
8 ops.
Buy Volume
€3m
1 ops.
Sell Volume
10Σ signal
Buys €56,689€3m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,772 of 25,936 companies
59.6
score / 100
Value
42
Quality
77
FCF yld-1.1%
Earn yld2.9%
EV/EBITDA·
ROE19%
Gross mgn56%
Net mgn11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.